{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T05:22:40Z","timestamp":1794460960174,"version":"4.9.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"LoLiPharma srl"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Basic Clin. Androl."],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Androgen deficiency affects men in the adulthood, causing several harmful effects at the reproductive and behavioural levels. Since aromatase is an enzyme that catalyses the conversion of androgens to estrogens, and it is responsible for an adequate balance of both sex hormones in males and females, the administration of molecules acting as down modulators may contribute to restore an abnormal enzymatic activity. A prospective pilot study was carried out to investigate the effect of D-chiro-inositol, a putative aromatase down-modulator, on serum levels of testosterone, estradiol, estrone, dehydroepiandrosterone and epiandrosterone from a group of adult male volunteers. Glucose, insulin, follicle-stimulating hormone, luteinizing hormone, inhibin B, D-chiro-inositol and myo-inositol serum levels were also measured.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Male volunteers were selected according to age and body mass index. Subjects with altered glycemia and\/or hormonal status, due to advanced age or abnormal weight, were enrolled in the study. Each of the 10 volunteers enrolled took oral D-chiro-inositol (1\u2009g\/day) for 1 month. Serum assays of selected markers were performed at baseline (control) and after treatment. D-chiro-inositol administration was associated to reduced serum levels of estrone (\u2212\u200985.0%) and estradiol (\u2212\u200914.4%), and increased serum levels of testosterone (+\u200923.4%) and dehydroepiandrosterone (+\u200913.8%). In addition, epiandrosterone levels were higher (+39%) after treatment. On the other hand, follicle-stimulating hormone, luteinizing hormone and inhibin B did not change. A trend toward a decrease of glycemia, insulinemia and Homeostatic Model Assessment index was observed after D-chiro-inositol treatment, although differences did not reach statistical significance. D-chiro-inositol treatment did not cause any noticeable adverse effect.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Increased androgens and decreased estrogens seem to confirm that D-chiro-inositol acts as an aromatase down-modulator, but with a still unknown mechanism of action. This pilot study opens up new perspectives of research and therapeutic applications for D-chiro-inositol at different dosages and length of treatment.<\/jats:p>\n                <jats:p>Authorization number 005\/2020 released by the Local Ethics Committee of Alma Res Fertility Center, Rome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration number<\/jats:title>\n                <jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04615767\">NCT04615767<\/jats:ext-link> (registry: ClinicalTrials.gov)<\/jats:p>\n                <jats:p>Date of registration: November 3, 2020<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12610-021-00131-x","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T02:22:21Z","timestamp":1622686941000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["D-chiro-inositol, an aromatase down-modulator, increases androgens and reduces estrogens in male volunteers: a pilot study"],"prefix":"10.1186","volume":"31","author":[{"given":"Giovanni","family":"Monastra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Vazquez-Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Salome","family":"Bezerra Espinola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Bilotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Simone","family":"Lagan\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1805-3181","authenticated-orcid":false,"given":"Vittorio","family":"Unfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,3]]},"reference":[{"issue":"1","key":"131_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000471876","volume":"88","author":"E Benyi","year":"2017","unstructured":"Benyi E, Savendahl L. The physiology of childhood growth: hormonal regulation. Horm Res Paediatr. 2017;88(1):6\u201314. https:\/\/doi.org\/10.1159\/000471876.","journal-title":"Horm Res Paediatr"},{"issue":"12","key":"131_CR2","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1172\/JCI10942","volume":"106","author":"A Falahati-Nini","year":"2000","unstructured":"Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest. 2000;106(12):1553\u201360. https:\/\/doi.org\/10.1172\/JCI10942.","journal-title":"J Clin Invest"},{"issue":"2","key":"131_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/tam.5.2.98.102","volume":"5","author":"A Vermeulen","year":"2002","unstructured":"Vermeulen A, Kaufman JM, Goemaere S, van Pottelberg I. Estradiol in elderly men. Aging Male. 2002;5(2):98\u2013102. https:\/\/doi.org\/10.1080\/tam.5.2.98.102.","journal-title":"Aging Male"},{"issue":"4","key":"131_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2164\/jandrol.107.004416","volume":"29","author":"JD Meeker","year":"2008","unstructured":"Meeker JD, Singh NP, Hauser R. Serum concentrations of estradiol and free T4 are inversely correlated with sperm DNA damage in men from an infertility clinic. J Androl. 2008;29(4):379\u201388. https:\/\/doi.org\/10.2164\/jandrol.107.004416.","journal-title":"J Androl"},{"issue":"6","key":"131_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1530\/eje.0.1490583","volume":"149","author":"M Muller","year":"2003","unstructured":"Muller M, den Tonkelaar I, Thijssen JH, Grobbee DE, van der Schouw YT. Endogenous sex hormones in men aged 40-80 years. Eur J Endocrinol. 2003;149(6):583\u20139. https:\/\/doi.org\/10.1530\/eje.0.1490583.","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"131_CR6","doi-asserted-by":"publisher","first-page":"5076","DOI":"10.1210\/jc.2003-030611","volume":"88","author":"M Muller","year":"2003","unstructured":"Muller M, van der Schouw YT, Thijssen JH, Grobbee DE. Endogenous sex hormones and cardiovascular disease in men. J Clin Endocrinol Metab. 2003;88(11):5076\u201386. https:\/\/doi.org\/10.1210\/jc.2003-030611.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"131_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.steroids.2011.10.013","volume":"77","author":"C Stocco","year":"2012","unstructured":"Stocco C. Tissue physiology and pathology of aromatase. Steroids. 2012;77(1\u20132):27\u201335. https:\/\/doi.org\/10.1016\/j.steroids.2011.10.013.","journal-title":"Steroids."},{"issue":"11","key":"131_CR8","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1161\/01.RES.84.11.1285","volume":"84","author":"N Harada","year":"1999","unstructured":"Harada N, Sasano H, Murakami H, Ohkuma T, Nagura H, Takagi Y. Localized expression of aromatase in human vascular tissues. Circ Res. 1999;84(11):1285\u201391. https:\/\/doi.org\/10.1161\/01.RES.84.11.1285.","journal-title":"Circ Res"},{"issue":"4","key":"131_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0960-0760(03)00059-1","volume":"84","author":"AA Larionov","year":"2003","unstructured":"Larionov AA, Vasyliev DA, Mason JI, Howie AF, Berstein LM, Miller WR. Aromatase in skeletal muscle. J Steroid Biochem Mol Biol. 2003;84(4):485\u201392. https:\/\/doi.org\/10.1016\/S0960-0760(03)00059-1.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"131_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/cam4.85","volume":"2","author":"S Hata","year":"2013","unstructured":"Hata S, Miki Y, Saito R, Ishida K, Watanabe M, Sasano H. Aromatase in human liver and its diseases. Cancer Med. 2013;2(3):305\u201315. https:\/\/doi.org\/10.1002\/cam4.85.","journal-title":"Cancer Med"},{"issue":"1","key":"131_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00418-018-1708-3","volume":"151","author":"H Kobayashi","year":"2019","unstructured":"Kobayashi H, Yoshida S, Shirasawa N, Maeda K, Naito A. Expression and localization of aromatase in human gastric mucosa : Immunohistochemical study using biopsy materials. Histochem Cell Biol. 2019;151(1):21\u20138. https:\/\/doi.org\/10.1007\/s00418-018-1708-3.","journal-title":"Histochem Cell Biol"},{"issue":"6","key":"131_CR12","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1210\/endo-113-6-2155","volume":"113","author":"WH Cleland","year":"1983","unstructured":"Cleland WH, Mendelson CR, Simpson ER. Aromatase activity of membrane fractions of human adipose tissue stromal cells and adipocytes. Endocrinology. 1983;113(6):2155\u201360. https:\/\/doi.org\/10.1210\/endo-113-6-2155.","journal-title":"Endocrinology."},{"issue":"3","key":"131_CR13","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1152\/physrev.00018.2016","volume":"97","author":"PS Cooke","year":"2017","unstructured":"Cooke PS, Nanjappa MK, Ko C, Prins GS, Hess RA. Estrogens in male physiology. Physiol Rev. 2017;97(3):995\u20131043. https:\/\/doi.org\/10.1152\/physrev.00018.2016.","journal-title":"Physiol Rev"},{"issue":"4","key":"131_CR14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1152\/physiol.00054.2015","volume":"31","author":"J Blakemore","year":"2016","unstructured":"Blakemore J, Naftolin F. Aromatase: contributions to physiology and disease in women and men. Physiology (Bethesda). 2016;31(4):258\u201369. https:\/\/doi.org\/10.1152\/physiol.00054.2015.","journal-title":"Physiology (Bethesda)"},{"issue":"7","key":"131_CR15","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1210\/jc.2007-1972","volume":"93","author":"FC Wu","year":"2008","unstructured":"Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O'Neill TW, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European male aging study. J Clin Endocrinol Metab. 2008;93(7):2737\u201345. https:\/\/doi.org\/10.1210\/jc.2007-1972.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"131_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1210\/jcem.87.2.8201","volume":"87","author":"HA Feldman","year":"2002","unstructured":"Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002;87(2):589\u201398. https:\/\/doi.org\/10.1210\/jcem.87.2.8201.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"131_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1210\/jcem-60-1-174","volume":"60","author":"WH Cleland","year":"1985","unstructured":"Cleland WH, Mendelson CR, Simpson ER. Effects of aging and obesity on aromatase activity of human adipose cells. J Clin Endocrinol Metab. 1985;60(1):174\u20137. https:\/\/doi.org\/10.1210\/jcem-60-1-174.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"131_CR18","doi-asserted-by":"publisher","first-page":"5920","DOI":"10.1210\/jc.2003-031719","volume":"89","author":"AB Araujo","year":"2004","unstructured":"Araujo AB, O'Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM, et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts male aging study. J Clin Endocrinol Metab. 2004;89(12):5920\u20136. https:\/\/doi.org\/10.1210\/jc.2003-031719.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"131_CR19","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","volume":"86","author":"SM Harman","year":"2001","unstructured":"Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Baltimore longitudinal study of a. longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore longitudinal study of aging. J Clin Endocrinol Metab. 2001;86(2):724\u201331. https:\/\/doi.org\/10.1210\/jcem.86.2.7219.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"131_CR20","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/j.1742-1241.2006.00992.x","volume":"60","author":"T Mulligan","year":"2006","unstructured":"Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60(7):762\u20139. https:\/\/doi.org\/10.1111\/j.1742-1241.2006.00992.x.","journal-title":"Int J Clin Pract"},{"issue":"2","key":"131_CR21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1210\/jc.2003-031110","volume":"89","author":"JK Amory","year":"2004","unstructured":"Amory JK, Watts NB, Easley KA, Sutton PR, Anawalt BD, Matsumoto AM, et al. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab. 2004;89(2):503\u201310. https:\/\/doi.org\/10.1210\/jc.2003-031110.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6 Pt 1","key":"131_CR22","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1365-2605.2010.01117.x","volume":"34","author":"G Corona","year":"2011","unstructured":"Corona G, Monami M, Rastrelli G, Aversa A, Sforza A, Lenzi A, et al. Type 2 diabetes mellitus and testosterone: a meta-analysis study. Int J Androl. 2011;34(6 Pt 1):528\u201340. https:\/\/doi.org\/10.1111\/j.1365-2605.2010.01117.x.","journal-title":"Int J Androl"},{"issue":"6","key":"131_CR23","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.jsxm.2018.04.641","volume":"15","author":"G Corona","year":"2018","unstructured":"Corona G, Rastrelli G, Di Pasquale G, Sforza A, Mannucci E, Maggi M. Testosterone and cardiovascular risk: meta-analysis of interventional studies. J Sex Med. 2018;15(6):820\u201338. https:\/\/doi.org\/10.1016\/j.jsxm.2018.04.641.","journal-title":"J Sex Med"},{"issue":"1","key":"131_CR24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1056\/NEJMc1603665","volume":"375","author":"PJ Snyder","year":"2016","unstructured":"Snyder PJ, Ellenberg SS, Farrar JT. Testosterone treatment in older men. N Engl J Med. 2016;375(1):90. https:\/\/doi.org\/10.1056\/NEJMc1603665.","journal-title":"N Engl J Med"},{"issue":"7","key":"131_CR25","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1001\/jama.2016.21044","volume":"317","author":"SM Resnick","year":"2017","unstructured":"Resnick SM, Matsumoto AM, Stephens-Shields AJ, Ellenberg SS, Gill TM, Shumaker SA, et al. Testosterone treatment and cognitive function in older men with low testosterone and age-associated memory impairment. JAMA. 2017;317(7):717\u201327. https:\/\/doi.org\/10.1001\/jama.2016.21044.","journal-title":"JAMA."},{"issue":"3","key":"131_CR26","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.juro.2015.10.083","volume":"195","author":"G Brock","year":"2016","unstructured":"Brock G, Heiselman D, Maggi M, Kim SW, Rodriguez Vallejo JM, Behre HM, et al. Effect of testosterone solution 2% on testosterone concentration, sex drive and energy in Hypogonadal men: results of a placebo controlled study. J Urol. 2016;195(3):699\u2013705. https:\/\/doi.org\/10.1016\/j.juro.2015.10.083.","journal-title":"J Urol"},{"issue":"3","key":"131_CR27","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/cen.12664","volume":"83","author":"M Grossmann","year":"2015","unstructured":"Grossmann M, Hoermann R, Wittert G, Yeap BB. Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: a systematic review and meta-analysis of randomized controlled clinical trials. Clin Endocrinol. 2015;83(3):344\u201351. https:\/\/doi.org\/10.1111\/cen.12664.","journal-title":"Clin Endocrinol"},{"issue":"2","key":"131_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa1000485","volume":"363","author":"S Basaria","year":"2010","unstructured":"Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM, et al. Adverse events associated with testosterone administration. N Engl J Med. 2010;363(2):109\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1000485.","journal-title":"N Engl J Med"},{"issue":"8","key":"131_CR29","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.mayocp.2015.05.012","volume":"90","author":"J Baillargeon","year":"2015","unstructured":"Baillargeon J, Urban RJ, Morgentaler A, Glueck CJ, Baillargeon G, Sharma G, et al. Risk of venous thromboembolism in men receiving testosterone therapy. Mayo Clin Proc. 2015;90(8):1038\u201345. https:\/\/doi.org\/10.1016\/j.mayocp.2015.05.012.","journal-title":"Mayo Clin Proc"},{"key":"131_CR30","doi-asserted-by":"crossref","first-page":"i5968","DOI":"10.1136\/bmj.i5968","volume":"355","author":"C Martinez","year":"2016","unstructured":"Martinez C, Suissa S, Rietbrock S, Katholing A, Freedman B, Cohen AT, et al. Testosterone treatment and risk of venous thromboembolism: population based case-control study. BMJ. 2016;355:i5968.","journal-title":"BMJ."},{"issue":"1","key":"131_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1477-7827-9-93","volume":"9","author":"W de Ronde","year":"2011","unstructured":"de Ronde W, de Jong FH. Aromatase inhibitors in men: effects and therapeutic options. Reprod Biol Endocrinol. 2011;9(1):93. https:\/\/doi.org\/10.1186\/1477-7827-9-93.","journal-title":"Reprod Biol Endocrinol"},{"key":"131_CR32","doi-asserted-by":"crossref","unstructured":"Kalkanli A, Akdere H, Cevik G, Salabas E, Cilesiz NC, Kadioglu A. Hypergonadotropic Hypogonadism: Management Of Infertility. Curr Pharm Des. 2021;27(8):1\u20136.","DOI":"10.2174\/1381612826666201102110456"},{"issue":"7","key":"131_CR33","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/CIRCULATIONAHA.119.044750","volume":"141","author":"F Khosrow-Khavar","year":"2020","unstructured":"Khosrow-Khavar F, Filion KB, Bouganim N, Suissa S, Azoulay L. Aromatase inhibitors and the risk of cardiovascular outcomes in women with breast Cancer: a population-based cohort study. Circulation. 2020;141(7):549\u201359. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044750.","journal-title":"Circulation."},{"issue":"10","key":"131_CR34","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1080\/17425255.2016.1206887","volume":"12","author":"M Bizzarri","year":"2016","unstructured":"Bizzarri M, Fuso A, Dinicola S, Cucina A, Bevilacqua A. Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease. Expert Opin Drug Metab Toxicol. 2016;12(10):1181\u201396. https:\/\/doi.org\/10.1080\/17425255.2016.1206887.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"24","key":"131_CR35","doi-asserted-by":"publisher","first-page":"16904","DOI":"10.1016\/S0021-9258(18)41870-4","volume":"267","author":"Y Pak","year":"1992","unstructured":"Pak Y, Huang LC, Lilley KJ, Larner J. In vivo conversion of [3H] myoinositol to [3H] chiroinositol in rat tissues. J Biol Chem. 1992;267(24):16904\u201310. https:\/\/doi.org\/10.1016\/S0021-9258(18)41870-4.","journal-title":"J Biol Chem"},{"issue":"1","key":"131_CR36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/15604280212528","volume":"3","author":"J Larner","year":"2002","unstructured":"Larner J. D-chiro-inositol--its functional role in insulin action and its deficit in insulin resistance. Int J Exp Diabetes Res. 2002;3(1):47\u201360. https:\/\/doi.org\/10.1080\/15604280212528.","journal-title":"Int J Exp Diabetes Res"},{"issue":"11\u201312","key":"131_CR37","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2119\/molmed.2010.00107","volume":"16","author":"J Larner","year":"2010","unstructured":"Larner J, Brautigan DL, Thorner MO. D-chiro-inositol glycans in insulin signaling and insulin resistance. Mol Med. 2010;16(11\u201312):543\u201352. https:\/\/doi.org\/10.2119\/molmed.2010.00107.","journal-title":"Mol Med"},{"issue":"6","key":"131_CR38","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1210\/jcem.83.6.4886","volume":"83","author":"JE Nestler","year":"1998","unstructured":"Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998;83(6):2001\u20135. https:\/\/doi.org\/10.1210\/jcem.83.6.4886.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"131_CR39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12958-016-0189-2","volume":"14","author":"S Sacchi","year":"2016","unstructured":"Sacchi S, Marinaro F, Tondelli D, Lui J, Xella S, Marsella T, et al. Modulation of gonadotrophin induced steroidogenic enzymes in granulosa cells by d-chiroinositol. Reprod Biol Endocrinol. 2016;14(1):52. https:\/\/doi.org\/10.1186\/s12958-016-0189-2.","journal-title":"Reprod Biol Endocrinol"},{"issue":"24","key":"131_CR40","doi-asserted-by":"publisher","first-page":"10575","DOI":"10.26355\/eurrev_201912_19752","volume":"23","author":"AS Lagana","year":"2019","unstructured":"Lagana AS, Unfer V. D-Chiro-Inositol's action as aromatase inhibitor: rationale and potential clinical targets. Eur Rev Med Pharmacol Sci. 2019;23(24):10575\u20136. https:\/\/doi.org\/10.26355\/eurrev_201912_19752.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"131_CR41","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1080\/17425255.2020.1785429","volume":"16","author":"AS Lagana","year":"2020","unstructured":"Lagana AS, Garzon S, Unfer V. New clinical targets of d-chiro-inositol: rationale and potential applications. Expert Opin Drug Metab Toxicol. 2020;16(8):703\u201310. https:\/\/doi.org\/10.1080\/17425255.2020.1785429.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"131_CR42","first-page":"29","volume":"72","author":"BJ Ku","year":"2007","unstructured":"Ku BJ, Kim HJ, Park KS. The clinical study to evaluate the safety and efficacy of D-chiro-inositol in patients with type 2 diabetes. J Korean Intern Med. 2007;72(1):29\u201336.","journal-title":"J Korean Intern Med"},{"issue":"4","key":"131_CR43","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00592-016-0954-x","volume":"54","author":"AR Maurizi","year":"2017","unstructured":"Maurizi AR, Menduni M, Del Toro R, Kyanvash S, Maggi D, Guglielmi C, et al. A pilot study of D-chiro-inositol plus folic acid in overweight patients with type 1 diabetes. Acta Diabetol. 2017;54(4):361\u20135. https:\/\/doi.org\/10.1007\/s00592-016-0954-x.","journal-title":"Acta Diabetol"},{"issue":"17","key":"131_CR44","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1056\/NEJM199904293401703","volume":"340","author":"JE Nestler","year":"1999","unstructured":"Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N Engl J Med. 1999;340(17):1314\u201320. https:\/\/doi.org\/10.1056\/NEJM199904293401703.","journal-title":"N Engl J Med"},{"issue":"5","key":"131_CR45","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00404-014-3552-6","volume":"291","author":"AS Lagana","year":"2015","unstructured":"Lagana AS, Barbaro L, Pizzo A. Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with D-Chiro-inositol. Arch Gynecol Obstet. 2015;291(5):1181\u20136. https:\/\/doi.org\/10.1007\/s00404-014-3552-6.","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"131_CR46","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3109\/09513590.2015.1014784","volume":"31","author":"A Cianci","year":"2015","unstructured":"Cianci A, Panella M, Fichera M, Falduzzi C, Bartolo M, Caruso S. D-chiro-inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS. Gynecol Endocrinol. 2015;31(6):483\u20136. https:\/\/doi.org\/10.3109\/09513590.2015.1014784.","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"131_CR47","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1080\/09513590.2018.1540573","volume":"35","author":"F Fruzzetti","year":"2019","unstructured":"Fruzzetti F, Capozzi A, Canu A, Lello S. Treatment with d-chiro-inositol and alpha lipoic acid in the management of polycystic ovary syndrome. Gynecol Endocrinol. 2019;35(6):506\u201310. https:\/\/doi.org\/10.1080\/09513590.2018.1540573.","journal-title":"Gynecol Endocrinol"},{"issue":"9","key":"131_CR48","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/09513590.2020.1737007","volume":"36","author":"PG Artini","year":"2020","unstructured":"Artini PG, Obino MER, Micelli E, Malacarne E, Vacca C, Papini F, et al. Effect of d-chiro-inositol and alpha-lipoic acid combination on COH outcomes in overweight\/obese PCOS women. Gynecol Endocrinol. 2020;36(9):755\u20139. https:\/\/doi.org\/10.1080\/09513590.2020.1737007.","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"131_CR49","first-page":"20","volume":"117","author":"DS Aschenbrenner","year":"2017","unstructured":"Aschenbrenner DS. Serious adverse effects of testosterone abuse. Am J Nurs. 2017;117(2):20\u20131.","journal-title":"Am J Nurs"},{"issue":"1\u20132","key":"131_CR50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cca.2009.09.039","volume":"411","author":"J Jiang","year":"2010","unstructured":"Jiang J, Tang NL, Ohlsson C, Eriksson AL, Vandenput L, Chan FW, et al. Association of genetic variations in aromatase gene with serum estrogen and estrogen\/testosterone ratio in Chinese elderly men. Clin Chim Acta. 2010;411(1\u20132):53\u20138. https:\/\/doi.org\/10.1016\/j.cca.2009.09.039.","journal-title":"Clin Chim Acta"},{"issue":"9","key":"131_CR51","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.2174\/1567201815666180509102641","volume":"15","author":"G Monastra","year":"2018","unstructured":"Monastra G, Sambuy Y, Ferruzza S, Ferrari D, Ranaldi G. Alpha-lactalbumin effect on Myo-inositol intestinal absorption: in vivo and in vitro. Curr Drug Deliv. 2018;15(9):1305\u201311. https:\/\/doi.org\/10.2174\/1567201815666180509102641.","journal-title":"Curr Drug Deliv"},{"issue":"3","key":"131_CR52","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/andr.12025","volume":"3","author":"AE Calogero","year":"2015","unstructured":"Calogero AE, Gullo G, La Vignera S, Condorelli RA, Vaiarelli A. Myoinositol improves sperm parameters and serum reproductive hormones in patients with idiopathic infertility: a prospective double-blind randomized placebo-controlled study. Andrology. 2015;3(3):491\u20135. https:\/\/doi.org\/10.1111\/andr.12025.","journal-title":"Andrology."},{"issue":"6","key":"131_CR53","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1530\/EJE-14-0932","volume":"172","author":"AL Barbotin","year":"2015","unstructured":"Barbotin AL, Ballot C, Sigala J, Ramdane N, Duhamel A, Marcelli F, et al. The serum inhibin B concentration and reference ranges in normozoospermia. Eur J Endocrinol. 2015;172(6):669\u201376. https:\/\/doi.org\/10.1530\/EJE-14-0932.","journal-title":"Eur J Endocrinol"},{"key":"131_CR54","doi-asserted-by":"crossref","unstructured":"Condorelli RA, Barbagallo F, Calogero AE, Cannarella R, Crafa A, La Vignera S. D-Chiro-Inositol Improves Sperm Mitochondrial Membrane Potential: In Vitro Evidence. J Clin Med. 2020;9(5):1\u20137.","DOI":"10.3390\/jcm9051373"},{"issue":"2","key":"131_CR55","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/09513590.2016.1254179","volume":"33","author":"PG Artini","year":"2017","unstructured":"Artini PG, Casarosa E, Carletti E, Monteleone P, Di Noia A, Di Berardino OM. In vitro effect of myo-inositol on sperm motility in normal and oligoasthenospermia patients undergoing in vitro fertilization. Gynecol Endocrinol. 2017;33(2):109\u201312. https:\/\/doi.org\/10.1080\/09513590.2016.1254179.","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"131_CR56","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1177\/0394632016644446","volume":"29","author":"RA Condorelli","year":"2016","unstructured":"Condorelli RA, Calogero AE, La Vignera S. Hyperestrogenism and low serum testosterone-17beta-estradiol ratio are associated with non-bacterial male accessory gland inflammation. Int J Immunopathol Pharmacol. 2016;29(3):488\u201393. https:\/\/doi.org\/10.1177\/0394632016644446.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"131_CR57","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3389\/fendo.2020.00621","volume":"11","author":"S Sun","year":"2020","unstructured":"Sun S, Jiao M, Han C, Zhang Q, Shi W, Shi J, et al. Causal Effects of Genetically Determined Metabolites on Risk of Polycystic Ovary Syndrome: A Mendelian Randomization Study. Front Endocrinol (Lausanne). 2020;11:621.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"131_CR58","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.2337\/dc12-2477","volume":"36","author":"GK Jasuja","year":"2013","unstructured":"Jasuja GK, Travison TG, Davda M, Rose AJ, Zhang A, Kushnir MM, et al. Circulating estrone levels are associated prospectively with diabetes risk in men of the Framingham heart study. Diabetes Care. 2013;36(9):2591\u20136. https:\/\/doi.org\/10.2337\/dc12-2477.","journal-title":"Diabetes Care"},{"issue":"3","key":"131_CR59","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cmet.2011.08.005","volume":"14","author":"RP Barros","year":"2011","unstructured":"Barros RP, Gustafsson JA. Estrogen receptors and the metabolic network. Cell Metab. 2011;14(3):289\u201399. https:\/\/doi.org\/10.1016\/j.cmet.2011.08.005.","journal-title":"Cell Metab"},{"issue":"1\u20133","key":"131_CR60","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jsbmb.2010.06.012","volume":"122","author":"A Foryst-Ludwig","year":"2010","unstructured":"Foryst-Ludwig A, Kintscher U. Metabolic impact of estrogen signalling through ERalpha and ERbeta. J Steroid Biochem Mol Biol. 2010;122(1\u20133):74\u201381. https:\/\/doi.org\/10.1016\/j.jsbmb.2010.06.012.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"131_CR61","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.fertnstert.2007.03.083","volume":"89","author":"M Nagamani","year":"2008","unstructured":"Nagamani M, Szymajda A, Sepilian V, Urban RJ, Gilkison C. Effects of raloxifene on insulin sensitivity, beta-cell function, and hepatic insulin extraction in normal postmenopausal women. Fertil Steril. 2008;89(3):614\u20139. https:\/\/doi.org\/10.1016\/j.fertnstert.2007.03.083.","journal-title":"Fertil Steril"},{"issue":"11","key":"131_CR62","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.tem.2018.09.001","volume":"29","author":"AS Lagana","year":"2018","unstructured":"Lagana AS, Garzon S, Casarin J, Franchi M, Ghezzi F. Inositol in polycystic ovary syndrome: restoring fertility through a pathophysiology-based approach. Trends Endocrinol Metab. 2018;29(11):768\u201380. https:\/\/doi.org\/10.1016\/j.tem.2018.09.001.","journal-title":"Trends Endocrinol Metab"},{"issue":"9","key":"131_CR63","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1080\/09513590.2016.1188282","volume":"32","author":"EM Milewska","year":"2016","unstructured":"Milewska EM, Czyzyk A, Meczekalski B, Genazzani AD. Inositol and human reproduction. From cellular metabolism to clinical use. Gynecol Endocrinol. 2016;32(9):690\u20135. https:\/\/doi.org\/10.1080\/09513590.2016.1188282.","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"131_CR64","doi-asserted-by":"publisher","first-page":"9387","DOI":"10.1002\/jcp.27623","volume":"234","author":"A Bevilacqua","year":"2019","unstructured":"Bevilacqua A, Dragotto J, Giuliani A, Bizzarri M. Myo-inositol and D-chiro-inositol (40:1) reverse histological and functional features of polycystic ovary syndrome in a mouse model. J Cell Physiol. 2019;234(6):9387\u201398. https:\/\/doi.org\/10.1002\/jcp.27623.","journal-title":"J Cell Physiol"},{"issue":"12","key":"131_CR65","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.26355\/eurrev_201906_18223","volume":"23","author":"M Nordio","year":"2019","unstructured":"Nordio M, Basciani S, Camajani E. The 40:1 myo-inositol\/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios. Eur Rev Med Pharmacol Sci. 2019;23(12):5512\u201321. https:\/\/doi.org\/10.26355\/eurrev_201906_18223.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"131_CR66","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/17425255.2020.1737675","volume":"16","author":"F Facchinetti","year":"2020","unstructured":"Facchinetti F, Appetecchia M, Aragona C, Bevilacqua A, Bezerra Espinola MS, Bizzarri M, et al. Experts' opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond. Expert Opin Drug Metab Toxicol. 2020;16(3):255\u201374. https:\/\/doi.org\/10.1080\/17425255.2020.1737675.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"21","key":"131_CR67","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.1021\/acs.jafc.9b01253","volume":"67","author":"F Cheng","year":"2019","unstructured":"Cheng F, Han L, Xiao Y, Pan C, Li Y, Ge X, et al. D- chiro-inositol ameliorates high fat diet-induced hepatic Steatosis and insulin resistance via PKCepsilon-PI3K\/AKT pathway. J Agric Food Chem. 2019;67(21):5957\u201367. https:\/\/doi.org\/10.1021\/acs.jafc.9b01253.","journal-title":"J Agric Food Chem"},{"issue":"11","key":"131_CR68","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/S0026-0495(99)90153-1","volume":"48","author":"K Yoshino","year":"1999","unstructured":"Yoshino K, Takeda N, Sugimoto M, Nakashima K, Okumura S, Hattori J, et al. Differential effects of troglitazone and D-chiroinositol on glucosamine-induced insulin resistance in vivo in rats. Metabolism. 1999;48(11):1418\u201323. https:\/\/doi.org\/10.1016\/S0026-0495(99)90153-1.","journal-title":"Metabolism."},{"issue":"4\u20136","key":"131_CR69","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/0960-0760(93)90249-V","volume":"44","author":"JE Nestler","year":"1993","unstructured":"Nestler JE. Regulation of the aromatase activity of human placental cytotrophoblasts by insulin, insulin-like growth factor-I, and -II. J Steroid Biochem Mol Biol. 1993;44(4\u20136):449\u201357. https:\/\/doi.org\/10.1016\/0960-0760(93)90249-V.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"10","key":"131_CR70","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.tics.2010.07.005","volume":"14","author":"M Hines","year":"2010","unstructured":"Hines M. Sex-related variation in human behavior and the brain. Trends Cogn Sci. 2010;14(10):448\u201356. https:\/\/doi.org\/10.1016\/j.tics.2010.07.005.","journal-title":"Trends Cogn Sci"},{"issue":"3","key":"131_CR71","doi-asserted-by":"publisher","first-page":"435","DOI":"10.4103\/1008-682X.173932","volume":"18","author":"M Schulster","year":"2016","unstructured":"Schulster M, Bernie AM, Ramasamy R. The role of estradiol in male reproductive function. Asian J Androl. 2016;18(3):435\u201340. https:\/\/doi.org\/10.4103\/1008-682X.173932.","journal-title":"Asian J Androl"}],"container-title":["Basic and Clinical Andrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12610-021-00131-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12610-021-00131-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12610-021-00131-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T02:22:56Z","timestamp":1622686976000},"score":1,"resource":{"primary":{"URL":"https:\/\/bacandrology.biomedcentral.com\/articles\/10.1186\/s12610-021-00131-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,3]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["131"],"URL":"https:\/\/doi.org\/10.1186\/s12610-021-00131-x","relation":{},"ISSN":["2051-4190"],"issn-type":[{"value":"2051-4190","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,3]]},"assertion":[{"value":"3 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Local Ethics Committee of Alma Res Fertility Center in Rome (registration n. 005\/2020). The volunteers enrolled in the study provided their written informed consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was retrieved from the volunteers and is available.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Vittorio Unfer is an employee at Lo.Li. Pharma srl. (Rome, Italy). The other authors have no conflict of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}